Ge Z, Wang J, He L, Zhao M, Si Y, Chang S
Discov Oncol. 2024; 15(1):564.
PMID: 39406984
PMC: 11480302.
DOI: 10.1007/s12672-024-01442-x.
Mutsuddy A, Huggins J, Amrit A, Erdem C, Calhoun J, Birtwistle M
bioRxiv. 2024; .
PMID: 39253474
PMC: 11383287.
DOI: 10.1101/2024.08.23.609433.
Wu W, Daneker M, Turner K, Jolley M, Lu L
Small Methods. 2024; 9(1):e2400620.
PMID: 39091065
PMC: 11747890.
DOI: 10.1002/smtd.202400620.
Wang H, Arulraj T, Ippolito A, Popel A
NPJ Digit Med. 2024; 7(1):189.
PMID: 39014005
PMC: 11252162.
DOI: 10.1038/s41746-024-01188-4.
Wu W, Daneker M, Turner K, Jolley M, Lu L
ArXiv. 2024; .
PMID: 38745694
PMC: 11092874.
Modeling Tumor Growth Using Partly Conditional Survival Models: A Case Study in Colorectal Cancer.
Flynn J, Curry M, Zhao B, Yang H, Dercle L, Tito Fojo A
JCO Clin Cancer Inform. 2023; 7:e2200203.
PMID: 37713655
PMC: 10569775.
DOI: 10.1200/CCI.22.00203.
A data assimilation framework to predict the response of glioma cells to radiation.
Liu J, Ii D, Yang J, Yankeelov T
Math Biosci Eng. 2023; 20(1):318-336.
PMID: 36650768
PMC: 11165419.
DOI: 10.3934/mbe.2023015.
Opportunities for improving brain cancer treatment outcomes through imaging-based mathematical modeling of the delivery of radiotherapy and immunotherapy.
Hormuth 2nd D, Farhat M, Christenson C, Curl B, Quarles C, Chung C
Adv Drug Deliv Rev. 2022; 187:114367.
PMID: 35654212
PMC: 11165420.
DOI: 10.1016/j.addr.2022.114367.
Post-Radiotherapy PET Image Outcome Prediction by Deep Learning Under Biological Model Guidance: A Feasibility Study of Oropharyngeal Cancer Application.
Ji H, Lafata K, Mowery Y, Brizel D, Bertozzi A, Yin F
Front Oncol. 2022; 12:895544.
PMID: 35646643
PMC: 9135979.
DOI: 10.3389/fonc.2022.895544.
Integrating mechanism-based modeling with biomedical imaging to build practical digital twins for clinical oncology.
Wu C, Lorenzo G, Hormuth 2nd D, Lima E, Slavkova K, DiCarlo J
Biophys Rev (Melville). 2022; 3(2):021304.
PMID: 35602761
PMC: 9119003.
DOI: 10.1063/5.0086789.
Quantitative magnetic resonance imaging and tumor forecasting of breast cancer patients in the community setting.
Jarrett A, Kazerouni A, Wu C, Virostko J, Sorace A, DiCarlo J
Nat Protoc. 2021; 16(11):5309-5338.
PMID: 34552262
PMC: 9753909.
DOI: 10.1038/s41596-021-00617-y.
Multi-parametric MRI (mpMRI) for treatment response assessment of radiation therapy.
Wang C, Padgett K, Su M, Mellon E, Maziero D, Chang Z
Med Phys. 2021; 49(4):2794-2819.
PMID: 34374098
PMC: 9769892.
DOI: 10.1002/mp.15130.
Bridging cell-scale simulations and radiologic images to explain short-time intratumoral oxygen fluctuations.
Kingsley J, Costello J, Raghunand N, Rejniak K
PLoS Comput Biol. 2021; 17(7):e1009206.
PMID: 34310608
PMC: 8341701.
DOI: 10.1371/journal.pcbi.1009206.
Digital twinning of Cellular Capsule Technology: Emerging outcomes from the perspective of porous media mechanics.
Urcun S, Rohan P, Skalli W, Nassoy P, Bordas S, Sciume G
PLoS One. 2021; 16(7):e0254512.
PMID: 34252146
PMC: 8274916.
DOI: 10.1371/journal.pone.0254512.
Biologically-Based Mathematical Modeling of Tumor Vasculature and Angiogenesis via Time-Resolved Imaging Data.
Hormuth 2nd D, Phillips C, Wu C, Lima E, Lorenzo G, Jha P
Cancers (Basel). 2021; 13(12).
PMID: 34208448
PMC: 8234316.
DOI: 10.3390/cancers13123008.
Math, magnets, and medicine: enabling personalized oncology.
Hormuth 2nd D, Jarrett A, Lorenzo G, Lima E, Wu C, Chung C
Expert Rev Precis Med Drug Dev. 2021; 6(2):79-81.
PMID: 34027102
PMC: 8133535.
DOI: 10.1080/23808993.2021.1878023.
Image-based personalization of computational models for predicting response of high-grade glioma to chemoradiation.
Hormuth 2nd D, Al Feghali K, Elliott A, Yankeelov T, Chung C
Sci Rep. 2021; 11(1):8520.
PMID: 33875739
PMC: 8055874.
DOI: 10.1038/s41598-021-87887-4.
Integrating Quantitative Assays with Biologically Based Mathematical Modeling for Predictive Oncology.
Kazerouni A, Gadde M, Gardner A, Hormuth 2nd D, Jarrett A, Johnson K
iScience. 2020; 23(12):101807.
PMID: 33299976
PMC: 7704401.
DOI: 10.1016/j.isci.2020.101807.
Preclinical Applications of Multi-Platform Imaging in Animal Models of Cancer.
Serkova N, Glunde K, Haney C, Farhoud M, De Lille A, Redente E
Cancer Res. 2020; 81(5):1189-1200.
PMID: 33262127
PMC: 8026542.
DOI: 10.1158/0008-5472.CAN-20-0373.
Towards integration of Cu-DOTA-trastuzumab PET-CT and MRI with mathematical modeling to predict response to neoadjuvant therapy in HER2 + breast cancer.
Jarrett A, Hormuth D, Adhikarla V, Sahoo P, Abler D, Tumyan L
Sci Rep. 2020; 10(1):20518.
PMID: 33239688
PMC: 7688955.
DOI: 10.1038/s41598-020-77397-0.